AKT1 and extranodal nasal NK/T cell lymphoma: In the past decade, however, several oncogenic pathways, including Janus kinase (JAK)—signal transducer and activator of transcription (STAT), mitogen-activated protein kinase (MAPK), AKT, and NF-κB signaling pathways, have been identified in the development of NKTCL by gene expression profiling15–20.